I'm hoping someone could provide some insights on interpreting the HC recall requirements when it comes to a hardware specification issue?
We have a certain assembly in our product that is certified to a certain test standard and for which we need to maintain traceability of certain raw components to an online database in order to retain our certification. We recently discovered that our supplier changed the sourcing of one of those components and now we cannot trace that component to the online database as required by the standard. There is no functional impact because the material composition of the component is the same. However we recently failed a source inspection by a standards inspector because of this.
I am wondering if this falls within the definition in GUI54 4.1.b which is as follows:
(b) may fail to conform to any claim made by the manufacturer or importer relating to its effectiveness, benefits, performance characteristics or safety
There is no functional or performance impact as a result of this issue, only that we cannot claim compliance with the standard. However we have product out in the field with this certification marking and I am therefore wondering if we have an obligation of notifying customers of this from a Health Canada perspective?
From an ISO 9001 perspective I believe we should notify customers. If we choose to do so because of ISO 9001, does this mean this enacts the HC recall requirements?
I appreciate any information anyone could provide regarding this.
Dave
We have a certain assembly in our product that is certified to a certain test standard and for which we need to maintain traceability of certain raw components to an online database in order to retain our certification. We recently discovered that our supplier changed the sourcing of one of those components and now we cannot trace that component to the online database as required by the standard. There is no functional impact because the material composition of the component is the same. However we recently failed a source inspection by a standards inspector because of this.
I am wondering if this falls within the definition in GUI54 4.1.b which is as follows:
(b) may fail to conform to any claim made by the manufacturer or importer relating to its effectiveness, benefits, performance characteristics or safety
There is no functional or performance impact as a result of this issue, only that we cannot claim compliance with the standard. However we have product out in the field with this certification marking and I am therefore wondering if we have an obligation of notifying customers of this from a Health Canada perspective?
From an ISO 9001 perspective I believe we should notify customers. If we choose to do so because of ISO 9001, does this mean this enacts the HC recall requirements?
I appreciate any information anyone could provide regarding this.
Dave